Table 2.
Subset of Research Cases: 1–24 used for Figures; 1–48 used for TMEM106B Genotype at residue 185
Case | TMEM106B genotype | Birth sex | Age at death (Years) |
Primary neuropathological diagnosis | |
---|---|---|---|---|---|
1 | TT | Female | 81 | Alzheimer disease, Sporadic | 1a,1b,1e,1f |
2 | SS | Female | 81 | Alzheimer disease, Sporadic | S1a,S1b |
3 | TT | Female | 87 | Alzheimer disease, Sporadic | 1c,1d,1 g,1 h,2a,2b,2e,2f,3,5a, 9 |
4 | TS | Female | 82 | Alzheimer disease, Sporadic | S2a,S2b,S2c,S2d |
5 | TS | Female | 96 | Alzheimer disease, Sporadic | 2 g,2 h |
6 | TT | Male | 67 | FTLD-TDP Type A (GRN), Hereditary | 4c |
7 | TS | Female | 93 | Alzheimer disease, Sporadic | 4d |
8 | TS | Female | 97 | Alzheimer disease, Sporadic | 4e,5b,6,8a,S6 |
9 | TT | Female | 63 | FTLD-Tau, Hereditary | 4a |
10 | TT | Female | 67 | Alzheimer disease, Dominantly Inherited | 4b |
11 | TT | Male | 93 | Alzheimer disease, Sporadic | 7,S7a,S7b,S8a,S8b |
12 | TT | Female | 70 | Alzheimer disease, Sporadic | 3 |
13 | TT | Female | 68 | Alzheimer disease, Sporadic | 3 |
14 | TT | Male | 61 | Alzheimer disease, Sporadic | 3,9 |
15 | TS | Male | 87 | Diffuse Lewy body disease | 3 |
16 | TT | Female | 91 | Alzheimer disease, Sporadic | 3 |
17 | TT | Male | 70 | Alzheimer disease, Sporadic | 3 |
18 | TT | Male | 57 | Alzheimer disease, Sporadic | 3 |
19 | TT | Female | 70 | Alzheimer disease, Sporadic | 3 |
20 | TT | Female | 60 | Alzheimer disease, Sporadic | 3,9 |
21 | TS | Female | 85 | Alzheimer disease, Sporadic | 2c,2d |
22 | TS | Male | 78 | Alzheimer disease, Sporadic | 4f,S5a,S5b |
23 | TS | Female | 71 | Alzheimer disease, Sporadic | 8b |
24 | TT | Male | 61 | Alzheimer disease, Sporadic | S4a,S4b,S4c,S4d |
25 | TT | Female | 50 | FTLD-TDP43, Hereditary | N/A |
26 | TT | Female | 75 | FTLD-TDP43, Hereditary | N/A |
27 | TT | Female | 42 | FTLD-TDP43, Hereditary | N/A |
28 | TT | Female | 59 | FTLD-TDP43, Hereditary | N/A |
29 | TT | Male | 34 | To be determined | N/A |
30 | TT | Female | 66 | FTLD-Tau, Sporadic | N/A |
31 | TT | Male | 91 | To be determined | N/A |
32 | TT | Female | 58 | Alzheimer disease, Sporadic | N/A |
33 | TT | Male | 63 | Alzheimer disease, Sporadic | N/A |
34 | TT | Male | 64 | Diffuse Lewy body disease | N/A |
35 | TS | Male | 80 | Diffuse Lewy body disease | N/A |
36 | TS | Male | 74 | To Be Determined | N/A |
37 | TS | Female | 66 | FTLD-TDP43, Hereditary | N/A |
38 | TS | Male | 84 | To be determined | N/A |
39 | TS | Female | 43 | Alzheimer disease, Hereditary | N/A |
40 | TS | Male | 76 | To be determined | N/A |
41 | TS | Female | 80 | To be determined | N/A |
42 | TS | Male | 59 | Alzheimer disease, Sporadic | N/A |
43 | TS | Female | 54 | Alzheimer disease, Hereditary | N/A |
44 | TS | Male | 74 | To be determined | N/A |
45 | SS | Female | 82 | To be determined | N/A |
46 | SS | Male | 79 | To be determined | N/A |
47 | SS | Male | 63 | Diffuse Lewy body disease | N/A |
48 | SS | Female | 44 | Alzheimer disease, Hereditary | N/A |
Frontotemporal Lobar Degeneration (FTLD), TAR DNA-binding protein 43 (TDP-43), Granulin (GRN)